Nano X Imaging Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $7.48
- Today's High:
- $7.78
- Open Price:
- $7.58
- 52W Low:
- $5.31
- 52W High:
- $22.69
- Prev. Close:
- $7.66
- Volume:
- 534107
Company Statistics
- Market Cap.:
- $456.15 million
- Book Value:
- 3.483
- Revenue TTM:
- $9.60 million
- Operating Margin TTM:
- -634.25%
- Gross Profit TTM:
- $-6880000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -14.03%
- Return on Equity TTM:
- -44.36%
Company Profile
Nano X Imaging Ltd had its IPO on 2020-08-21 under the ticker symbol NNOX.
The company operates in the Healthcare sector and Medical Devices industry. Nano X Imaging Ltd has a staff strength of 180 employees.
Stock update
Shares of Nano X Imaging Ltd opened at $7.58 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $7.48 - $7.78, and closed at $7.56.
This is a -1.31% slip from the previous day's closing price.
A total volume of 534,107 shares were traded at the close of the day’s session.
In the last one week, shares of Nano X Imaging Ltd have slipped by -7.92%.
Nano X Imaging Ltd's Key Ratios
Nano X Imaging Ltd has a market cap of $456.15 million, indicating a price to book ratio of 2.0626 and a price to sales ratio of 65.4193.
In the last 12-months Nano X Imaging Ltd’s revenue was $9.60 million with a gross profit of $-6880000 and an EBITDA of $-49264000. The EBITDA ratio measures Nano X Imaging Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Nano X Imaging Ltd’s operating margin was -634.25% while its return on assets stood at -14.03% with a return of equity of -44.36%.
In Q2, Nano X Imaging Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 17.4%.
Nano X Imaging Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.84 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Nano X Imaging Ltd’s profitability.
Nano X Imaging Ltd stock is trading at a EV to sales ratio of 55.2334 and a EV to EBITDA ratio of -5.8731. Its price to sales ratio in the trailing 12-months stood at 65.4193.
Nano X Imaging Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $224.89 million
- Total Liabilities
- $23.43 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $344000
- Dividend Payout Ratio
- 0%
Nano X Imaging Ltd ended 2024 with $224.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $224.89 million while shareholder equity stood at $193.54 million.
Nano X Imaging Ltd ended 2024 with $0 in deferred long-term liabilities, $23.43 million in other current liabilities, 159000.00 in common stock, $-288582000.00 in retained earnings and $7.42 million in goodwill. Its cash balance stood at $42.00 million and cash and short-term investments were $74.46 million. The company’s total short-term debt was $448,000 while long-term debt stood at $3.43 million.
Nano X Imaging Ltd’s total current assets stands at $77.52 million while long-term investments were $5.82 million and short-term investments were $32.47 million. Its net receivables were $1.43 million compared to accounts payable of $3.97 million and inventory worth $901000.00.
In 2024, Nano X Imaging Ltd's operating cash flow was $0 while its capital expenditure stood at $344000.
Comparatively, Nano X Imaging Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $7.56
- 52-Week High
- $22.69
- 52-Week Low
- $5.31
- Analyst Target Price
- $32
Nano X Imaging Ltd stock is currently trading at $7.56 per share. It touched a 52-week high of $22.69 and a 52-week low of $22.69. Analysts tracking the stock have a 12-month average target price of $32.
Its 50-day moving average was $11.23 and 200-day moving average was $10.68 The short ratio stood at 7.11 indicating a short percent outstanding of 0%.
Around 1342.5% of the company’s stock are held by insiders while 1950.6% are held by institutions.
Frequently Asked Questions About Nano X Imaging Ltd
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was incorporated in 2018 and is based in Neve Ilan, Israel.